Senna-S
NDC 81005-102, Docusate Sodium 50 mg Sennosides 8.6 mg, tablet, film coated, from Aarkish Pharmaceuticals NJ Inc..
- Product NDC
- 81005-102
- Status
- Listed
- Labeler
- Aarkish Pharmaceuticals NJ Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81005-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SENNOSIDES8.6 mg/1
- DOCUSATE SODIUM50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81005-102-10 | 81005010210 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (81005-102-10) |
| 81005-102-30 | 81005010230 | 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (81005-102-30) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 81005-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81005-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81005-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.